Cardiavent Inc.
3991 Ramsgate Ct.
Ann Arbor, MI 48013
rsrobsim@gmail.com
About CARD-024
CARD-024 PRECLINICAL STUDIES SUMMARY
CARD-024 PHASE I CLINICAL STUDY
-
CARD-024 was safe and well tolerated in this study:
- No SAEs
- No clinically meaningful changes in clinical chemistry or hematological parameters, physical examination, ECG parameters or vital signs
-
Strong evidence of efficacy and biological effects
CARD-024 Intellectual Property
- Patents issued for Cardiovascular and Crohn's Disease use.
